Substituted benzoxanthone type compound and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A kind of technology of benzoxanthone and compound, applied in benzoxanthone compound and its application field in pharmacy, can solve the problem such as in vivo activity reduction, toxicity, achieve the effect of good antitumor activity
Inactive Publication Date: 2011-05-25
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF0 Cites 19 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0002] Camptothecin is a classic topoisomerase I inhibitor. At present, two drugs, topotecan and irinotecan, have entered clinical use. However, the E lactone ring of camp
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0067] Example 1: Synthesis of 8,10-hydroxybenzoxanthone
[0068] Put 10g of 1-hydroxy-2-naphthoic acid, 10g of phloroglucinol and 30g of zinc chloride in 70mL of phosphorus oxychloride, react at 70°C for 6 hours, stop the reaction, add 1.5L of water after cooling, stir overnight, pump A dark red solid was obtained by filtration and purified by column chromatography (THF:PE 1:8) to obtain 5.3 g of light yellow solid 8,10-hydroxybenzoxanthone (35.8%). 1 H NMR (500MHz, CDCl 3 ), δ12.91(s, 1H), 10.24(s, 1H), 8.62(d, J=7.9Hz, 1H), 8.14(d, J=8.7Hz, 1H), 7.94(d, J=7.9Hz , 1H), 7.72 (m, 3H), 6.60 (d, J=1.9Hz, 1H), 6.36 (d, J=1.9Hz, 1H).
Embodiment 2
[0069] Example 2: Synthesis of 8-hydroxy-10-methoxy-7H-benzoxanthone
[0070] According to the method of Example 1, 3,5-dimethoxyphenol was used instead of phloroglucinol to obtain 5.6 g of light yellow solid 8-hydroxyl-10-methoxyl-7H-benzoxanthone (36.1%) .
[0072] Example 3: Synthesis of 9,11-dibromo-8,10-dihydroxy-7H-benzoxanthone
[0073] Add 0.50g of 8,10-hydroxybenzoxanthone to 10mL of acetic acid, add 0.18mL of bromine dropwise, react at room temperature for 2h, and filter with suction to obtain 0.71g of yellow solid 9,11-dibromo-8,10-dihydroxy -7H-Benzoxanthone (91.0%). 1 H NMR (500MHz, CDCl 3 ) δ 7.70 (m, 3H), 7.91 (m, 1H), 8.16 (d, J=8.7Hz, 1H), 8.74 (m, 1H), 13.97 (s, 1H).
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to the technical field of medicine, in particular to a new benzoxanthone type compound and an application thereof in pharmacy. Benzoxanthone type derivatives are one type of topoisomerase I inhibitors in new structure, which are found in recent years, and have obvious cell proliferation activity. The invention provides the new benzoxanthone type compound and pharmaceutical salts thereof, and the structure of the compound is as shown in the general formula (I). The invention further provides the application of the benzoxanthone type compound and the pharmaceutical salts thereof in the preparation of the topoisomerase inhibitors, anti-tumor medicaments, antifungal medicaments, antiviral medicaments, anti-hypertensive medicaments or anti-thrombotic medicaments.
Description
technical field [0001] The invention relates to the technical field of medicine, in particular to a new class of benzoxanthone compounds and their application in pharmacy. Background technique [0002] Camptothecin is a classic topoisomerase I inhibitor. At present, two drugs, topotecan and irinotecan, have entered clinical use. However, the E lactone ring of camptothecin compounds is easily hydrolyzed in vivo to form a The active carboxylate form significantly reduces its in vivo activity and leads to its obvious toxicity. In order to solve the problem of camptothecin, non-camptothecin topoisomerase I inhibitors such as benzophenanthridine compounds, indenoisoquinolinones and indolocarbazoles have been obtained in recent years. [0003] Benzoxanthone derivatives are topoisomerase I inhibitors with a new structure discovered in recent years, and have obvious inhibitory activity on cell proliferation (such as Hee-Ju Cho et al.: New benzoxanthone derivatives as topoisomerase ...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more